scholarly journals A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1

2003 ◽  
Vol 187 (5) ◽  
pp. 725-735 ◽  
Author(s):  
Dhayendre Moodley ◽  
Jagidesa Moodley ◽  
Hoosen Coovadia ◽  
Glenda Gray ◽  
James McIntyre ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Child Transmission ◽  
Randomized Controlled ◽  
Early Postpartum ◽  
Multicenter Randomized Controlled Trial ◽  
Immunodeficiency Virus ◽  
Mother To Child

scholarly journals Short‐Course Therapy with Zidovudine Plus Lamivudine for Prevention of Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1 in Thailand

2002 ◽  
Vol 35 (11) ◽  
pp. 1405-1413 ◽  
Author(s):  
Pongsakdi Chaisilwattana ◽  
Kulkanya Chokephaibulkit ◽  
Amphan Chalermchockcharoenkit ◽  
Nirun Vanprapar ◽  
Korakot Sirimai ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Human Immunodeficiency Virus Type ◽  
Virus Type ◽  
Mother To Child Transmission ◽  
Child Transmission ◽  
Short Course ◽  
Immunodeficiency Virus ◽  
Mother To Child

scholarly journals Effect of Human Immunodeficiency Virus (HIV) Type 1 Viral Genotype on Mother‐to‐Child Transmission of HIV‐1

2000 ◽  
Vol 181 (2) ◽  
pp. 746-749 ◽  
Author(s):  
Melanie C. M. Murray ◽  
Joanne E. Embree ◽  
Sue G. Ramdahin ◽  
Aggrey O. Anzala ◽  
Simon Njenga ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Mother To Child Transmission ◽  
Viral Genotype ◽  
Child Transmission ◽  
Immunodeficiency Virus ◽  
Hiv Type 1 ◽  
Mother To Child ◽  
Hiv 1

scholarly journals Antiretroviral Therapy with a Twice-Daily Regimen Containing 400 Milligrams of Indinavir and 100 Milligrams of Ritonavir in Human Immunodeficiency Virus Type 1-Infected Women during Pregnancy

2008 ◽  
Vol 52 (4) ◽  
pp. 1542-1544 ◽  
Author(s):  
Jade Ghosn ◽  
Ines De Montgolfier ◽  
Chantal Cornélie ◽  
Stéphanie Dominguez ◽  
Claire Pérot ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Daily Regimen ◽  
Child Transmission ◽  
Third Trimester ◽  
Safety And Efficacy ◽  
Hiv Rna ◽  
The Third ◽  
Immunodeficiency Virus ◽  
Mother To Child

ABSTRACT We evaluated the safety and efficacy of a twice daily regimen containing 400 mg of indinavir and 100 mg of ritonavir in 32 human immunodeficiency virus (HIV)-infected women during pregnancy. The median indinavir trough concentration was 208 ng/ml during the third trimester. At delivery, 26 of 28 women on indinavir-ritonavir had HIV RNA levels of <200 copies/ml. No infant was HIV infected. These data are encouraging for the use of this combination for prevention of mother-to-child transmission of HIV.

Sign in / Sign up

Export Citation Format

Share Document